Index Every US public charity, on the record

Kaleidoscope of Hope Foundation Inc

Madison, New Jersey
EIN 22-3744037Grantmaking public charityLatest return year ending December 2024Its profile as a public charity

Applications

Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Kaleidoscope of Hope Foundation Inc accepts applications.

From its returns

What it gave

Kaleidoscope of Hope Foundation Inc paid $75,000 in grants in the year ending December 2024.

Grants paid
$75,000
Year ending December 2024
Grants listed
3
To organizations, on that return
Typical grant
$25,000
The median of the grants listed
Year endingGrants paidGrants listed
December 2024$75,0003
December 2023$152,7504

From Schedule I of its Form 990 returns for the years ending December 2023 to December 2024.

Focus and places

What it funds, and where

From the 7 grants listed on its returns for the years ending December 2023 to December 2024. A grant counts toward a focus only when it is linked to the charity that received it: 2 of 7 are.

Focus, by share of linked grant dollars

  • Education100%

Where it gave, by number of grants

  • Pennsylvania2
  • Georgia1
  • Ohio1
  • New Jersey1
  • Texas1
  • New York1

From Schedule I of its Form 990 returns for the years ending December 2023 to December 2024.

Grants

Recent grants to organizations

The largest grants on its latest returns, as filed. A name links to the charity’s profile when the match is certain.

RecipientYear endingAmountPurpose
CORPORATING MERCER UNIVERSITYMacon, GeorgiaDecember 2024$25,000TO SUPPORT OVARIAN CANCER RESEARCH
Ohio University FoundationAthens, OhioDecember 2024$25,000TO SUPPORT OVARIAN CANCER RESEARCH
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAPhiladelphia, PennsylvaniaDecember 2024$25,000INVESTIGATION OF A NOVEL P53 STABILIZING TARGETED TREATMENT COMBINATION IN TP53 WILD TYPE OVARIAN CANCER.
TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATIONNew York, New YorkDecember 2023$50,000UNDERSTANDING THE ROLE OF CARM 1 IN REGULATION OF CYTOKINE-MEDIATED ANTITUMOR RESPONSE IN OVARIAN CANCER.
TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIAPhiladelphia, PennsylvaniaDecember 2023$50,000INVESTIGATION OF A NOVEL P53 STABILIZING TARGETED TREATMENT COMBINATION IN TP53 WILD TYPE OVARIAN CANCER.
The Trustees of the Stevens Institute of TechnologyHoboken, New JerseyDecember 2023$25,000NUTRITIONAL SUPPLEMENT TAURINE SUPPRESSES OVARIAN CANCER.
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTERHouston, TexasDecember 2023$25,000TO IDENTIFY LIQUID BIOPSY (EXTRACELLULAR VESICLES)BASED MOLECULAR PREDICTORS OF DISEASE PATTERNS FROM PATIENTS FROM MATCHED TISSUES AND BLOOD FROM PATIENTS WITH COMPLETE GROSS RESECTION AND PATIENTS WITH EXCELLENT AND POOR RESPONSE TO CHEMOTHERAPY, FOLLOWED BY CLINICAL VALLIDATION OF OUR FINDING IN PATIENTS WITH HIGHGRADE SEROUS OVARIAN CANCER.

Showing 7 of the 7 grants listed on its returns for the years ending December 2023 to December 2024. From Schedule I of its Form 990 returns for the years ending December 2023 to December 2024.